Beamtree Holdings

Autonomous Clinical Coding Rollout Will Drive Long Term Healthcare Data Demand

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

04 Dec 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-15.7%

-2.3%

-15.7%

-2.3%

You can edit this narrative until Dec 5 6:05 AM. Then, changes will post as Updates.

Author's Valuation

AU$0.664.2% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

AU$0.6

64.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

18.74%

Healthtech revenue growth rate

10.86%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.92%

Calculation

AU$6.53m

Earnings '28

27.00x

PE Ratio '28

AU$176.19m

Market Cap '28

AU$176.19m

Market Cap '28

292.96m

No. shares '28

AU$0.60

Share Price '28

AU$0.60 Share Price '28

Discounted to 2025 @ 0.08% p.a.

AU$0.60

Fair Value '25